S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.46
+1.78
+10.67%
KMB · Kimberly-Clark Corporation
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
Kimberly-Clark Corp (KMB)
NASDAQ NMS - GLOBAL MARKET
Consumer products
$106.65
-1.66
(-1.54%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$106.65
$106.44
$107.96
52-WEEK RANGE
$106.65
$92.42
$123.09
What's happening
- KMB is down 1.54% today, trading at $106.65. — Live quote
- Volume today (223,858) is well below its 3-month average of 4,279,550. (Finnhub fundamentals)
- Reports earnings on 2026-11-05 (before market open), 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $2.12 actual vs. $2.03 estimated (+4.2%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 4
Buy 6
Hold 10
Sell 0
Strong sell 1
Aggregate ratings for 2026-10-01 (21 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
KMB
+5.70%
vs S&P 500
-7.67%
1-YEAR RETURN
KMB
-11.17%
vs S&P 500
-26.34%
6-MONTH RETURN
KMB
+7.89%
3-MONTH RETURN
KMB
-2.06%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$2.12
Est. $2.03
BEAT +4.2%
2026-04-26 (Q1 2026)
$1.97
Est. $1.91
BEAT +3.1%
2026-01-26 (Q4 2025)
$1.86
Est. $1.83
BEAT +1.7%
2025-10-26 (Q3 2025)
$1.82
Est. $1.77
BEAT +2.6%
Valuation Measures & Ratios
Enterprise Value4$41.19B
Forward P/E513.30
PEG Ratio611.73
Price / Sales (TTM1)2.15
Price / Book720.82
EV4 / Revenue2.48
EV4 / EBITDA12.72
Profit Margin11.79%
Operating Margin15.16%
Return on Equity (ROE8)122.57%
Return on Assets (ROA9)11.22%
Avg Volume (3M)4,279,550
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 |
|---|---|---|---|---|---|
| Market cap | $35.98B | $31.27B | $32.32B | $39.37B | $40.40B |
| P/E | 18.41 | 14.76 | 15.99 | 20.00 | 16.63 |
| Price/Sales | 2.17 | 1.89 | 1.97 | 2.39 | 2.45 |
| Price/Book | 20.56 | 17.41 | 21.52 | 29.56 | 31.79 |
| EV/Revenue | 2.11 | 1.86 | 1.92 | 2.35 | 2.42 |
| ROE | 111.71% | 117.98% | 134.55% | 147.82% | 191.19% |
| ROA | 10.54% | 12.33% | 11.82% | 11.66% | 14.49% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short53,177,521
Change from Prior Settlement+1.26%
% of Float—
Days to Cover (Short Ratio)14.23
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 0.6% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 11.8%. Finnhub fundamentals ↗
Potential concerns
- Trailing 52-week price return is -11.2%. Finnhub market metrics ↗
- Latest SEC filing is Form 8-K, filed 2026-10-20; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on KMB
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.19B | $4.16B | $4.08B | $4.15B | $4.16B | $4.05B | $4.10B | $4.14B |
| Gross profit | $1.60B | $1.53B | $1.47B | $1.49B | $1.46B | $1.51B | $1.45B | $1.56B |
| Operating income | $633.0M | $753.0M | — | $621.0M | $592.0M | $631.0M | — | $1.03B |
| Net income | $345.0M | $665.0M | $499.0M | $446.0M | $509.0M | $567.0M | $447.0M | $907.0M |
| EPS (diluted) | $1.04 | $2.00 | $1.50 | $1.34 | $1.53 | $1.70 | $1.34 | $2.69 |
| EPS (basic) | $1.04 | $2.00 | $1.50 | $1.34 | $1.53 | $1.71 | $1.34 | $2.70 |
| Operating margin | $15 | $18 | — | $15 | $14 | $16 | — | $25 |
| Net margin | $8 | $16 | $12 | $11 | $12 | $14 | $11 | $22 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $18.55B | $17.18B | $17.10B | $16.89B | $16.77B | $16.30B | $16.55B | $17.16B |
| Stockholders' equity | $1.75B | $1.80B | $1.50B | $1.33B | $1.27B | $1.10B | $840.0M | $1.28B |
| Total current assets | $6.35B | $5.29B | $5.31B | $5.47B | $5.56B | $5.28B | $5.58B | $5.85B |
| Total current liabilities | $6.99B | $6.90B | $7.12B | $7.08B | $7.17B | $6.92B | $7.00B | $7.07B |
| Cash & equivalents | $956.0M | $542.0M | $688.0M | $617.0M | $634.0M | $563.0M | $1.01B | $1.11B |
| Accounts receivable | $1.86B | $2.00B | $1.89B | $1.97B | $2.01B | $2.18B | $1.73B | $2.23B |
| Inventory | $1.54B | $1.48B | $1.48B | $1.54B | $1.56B | $1.91B | $1.45B | $1.94B |
| Other current assets | $636.0M | $547.0M | $535.0M | $570.0M | $572.0M | $633.0M | $694.0M | $570.0M |
| Property, plant & equipment | $6.95B | $6.83B | $6.78B | $6.53B | $6.32B | $7.51B | $6.28B | $7.70B |
| Goodwill | $1.83B | $1.84B | $1.84B | $1.83B | $1.84B | $1.97B | $1.80B | $2.06B |
| Intangible assets | $73.0M | $76.0M | $77.0M | — | — | — | $80.0M | — |
| Other non-current assets | $1.04B | $1.06B | $1.06B | $996.0M | $1.00B | $1.11B | $984.0M | $1.10B |
| Accounts payable | $3.37B | $3.25B | $3.39B | $3.23B | $3.25B | $3.60B | $3.26B | $3.64B |
| Accrued liabilities | $2.27B | $1.90B | $1.89B | $1.87B | $2.02B | $2.14B | $2.09B | $2.45B |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Other non-current liabilities | $622.0M | $623.0M | $646.0M | $653.0M | $680.0M | $683.0M | $609.0M | $751.0M |
| Common stock & paid-in capital | $473.0M | $473.0M | $473.0M | $473.0M | $473.0M | $473.0M | $473.0M | $473.0M |
| Retained earnings | $9.77B | $9.85B | $9.61B | $9.52B | $9.49B | $9.41B | $9.26B | $9.28B |
| Accumulated other comprehensive income (loss) | -$3.39B | -$3.41B | -$3.44B | -$3.50B | -$3.51B | -$3.63B | -$3.77B | -$3.56B |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $908.0M | $745.0M | $972.0M | $708.0M | $770.0M | $327.0M | $817.0M | $958.0M |
| Investing cash flow | -$410.0M | -$355.0M | -$301.0M | -$338.0M | -$193.0M | -$119.0M | -$194.0M | $470.0M |
| Financing cash flow | $305.0M | -$527.0M | -$608.0M | -$388.0M | -$500.0M | -$683.0M | -$686.0M | -$1.48B |
| Depreciation & amortization | $167.0M | $193.0M | $189.0M | $176.0M | $222.0M | $218.0M | $217.0M | $191.0M |
| Share-based compensation | $41.0M | $23.0M | $25.0M | $42.0M | $41.0M | $32.0M | $21.0M | $39.0M |
| Deferred income taxes | -$119.0M | $36.0M | $37.0M | $234.0M | -$37.0M | $7.0M | $48.0M | -$7.0M |
| Change in accounts receivable | — | — | $58.0M | — | — | — | -$48.0M | — |
| Change in inventory | — | — | -$70.0M | — | — | — | -$10.0M | — |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Other investing activities | -$8.0M | -$9.0M | -$11.0M | -$16.0M | -$24.0M | $2.0M | -$28.0M | -$16.0M |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | $0 | $0 | $1.0M | $20.0M | $59.0M | $61.0M | $248.0M | $596.0M |
| Debt issued | $1.33B | — | $0 | — | $0 | — | $0 | $0 |
| Debt repaid | $0 | $400.0M | $0 | $300.0M | $0 | $250.0M | $0 | $554.0M |
| Other financing activities | -$34.0M | -$7.0M | -$36.0M | -$17.0M | -$34.0M | -$24.0M | -$21.0M | -$3.0M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $16.45B | $16.80B | $17.15B | $20.18B | $19.44B |
| Gross profit | $5.92B | $6.29B | $6.27B | $6.22B | $5.99B |
| Operating income | $2.35B | $2.70B | $1.93B | $2.68B | $2.56B |
| Net income | $2.02B | $2.54B | $1.76B | $1.93B | $1.81B |
| EPS (diluted) | $6.07 | $7.55 | $5.21 | $5.72 | $5.35 |
| EPS (basic) | $6.09 | $7.58 | $5.22 | $5.73 | $5.38 |
| Operating margin | $14 | $16 | $11 | $13 | $13 |
| Net margin | $12 | $15 | $10 | $10 | $9 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $17.10B | $16.55B | $17.34B | $17.97B | $17.84B |
| Stockholders' equity | $1.50B | $840.0M | $915.0M | $547.0M | $514.0M |
| Total current assets | $5.31B | $5.58B | $5.70B | $5.73B | $5.57B |
| Total current liabilities | $7.12B | $7.00B | $6.93B | $7.33B | $6.75B |
| Cash & equivalents | $688.0M | $1.01B | $1.09B | $427.0M | $270.0M |
| Accounts receivable | $1.89B | $1.73B | $2.13B | $2.28B | $2.21B |
| Inventory | $1.48B | $1.45B | $1.96B | $2.27B | $2.24B |
| Other current assets | $535.0M | $694.0M | $520.0M | $753.0M | $849.0M |
| Property, plant & equipment | $6.78B | $6.28B | $7.91B | $7.88B | $8.10B |
| Goodwill | $1.84B | $1.80B | $1.89B | $2.07B | $1.84B |
| Intangible assets | $77.0M | $80.0M | $197.0M | $851.0M | $810.0M |
| Other non-current assets | $1.06B | $984.0M | $1.14B | $1.19B | $1.24B |
| Accounts payable | $3.39B | $3.26B | $3.65B | $3.81B | $3.84B |
| Accrued liabilities | $1.89B | $2.09B | $2.32B | $2.29B | $2.10B |
| Short-term debt | — | — | — | — | — |
| Long-term debt | — | — | — | — | — |
| Other non-current liabilities | $646.0M | $609.0M | $860.0M | $799.0M | $681.0M |
| Common stock & paid-in capital | $473.0M | $473.0M | $473.0M | $473.0M | $473.0M |
| Retained earnings | $9.61B | $9.26B | $8.37B | $8.20B | $7.86B |
| Accumulated other comprehensive income (loss) | -$3.44B | -$3.77B | -$3.58B | -$3.67B | -$3.24B |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $2.78B | $3.23B | $3.54B | $2.73B | $2.73B |
| Investing cash flow | -$951.0M | -$100.0M | -$418.0M | -$785.0M | -$1.06B |
| Financing cash flow | -$2.18B | -$3.17B | -$2.37B | -$1.76B | -$1.70B |
| Depreciation & amortization | $805.0M | $781.0M | $753.0M | $754.0M | $766.0M |
| Share-based compensation | $140.0M | $131.0M | $169.0M | $150.0M | $26.0M |
| Deferred income taxes | $241.0M | -$38.0M | -$322.0M | -$57.0M | -$70.0M |
| Change in accounts receivable | $58.0M | -$48.0M | -$127.0M | $151.0M | $37.0M |
| Change in inventory | -$70.0M | -$10.0M | -$290.0M | $76.0M | $417.0M |
| Purchases of investments | — | — | — | — | — |
| Other investing activities | -$49.0M | -$13.0M | -$8.0M | $14.0M | $10.0M |
| Dividends paid | — | — | $1.59B | $1.56B | $1.52B |
| Share repurchases | $141.0M | $1.00B | $225.0M | $100.0M | $400.0M |
| Debt issued | $0 | $0 | $363.0M | $0 | $605.0M |
| Debt repaid | $550.0M | $554.0M | $475.0M | $312.0M | $269.0M |
| Other financing activities | -$111.0M | -$86.0M | -$45.0M | -$47.0M | -$48.0M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding KMB as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-04-26 to 2026-07-31
Recent transactions
- Insiders have net sold 7,096 shares over the last 182 days, across 0 purchases and 3 sales.
- Most recent: Corsi Patricia (Chief Growth Officer) — Option exercise of 966 shares on 2026-07-31.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)7,096 sh(3 txns)
Net Shares-7,096
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Corsi Patricia | Chief Growth Officer | Option exercise | 2026-07-31 | 966 |
| Slavtcheff Craig | Chief R&D Officer | Option exercise | 2026-07-31 | 4,024 |
| Scribner Andrew | Controller, VP & FP&A | Open market sale | 2026-05-06 | 4,095 |
| Chen Katy | President, Int'l Personal Care | Open market sale | 2026-05-04 | 1,596 |
| Abou-Oaf Ehab | Pres. Int'l Fam. Care & Prof. | Option exercise | 2026-05-01 | 1,450 |
| Fenske Tamera | Chief Supply Chain Officer | Option exercise | 2026-05-01 | 2,582 |
| Urdaneta Nelson | Chief Financial Officer | Option exercise | 2026-05-01 | 3,384 |
| Torres Russell | President and COO | Option exercise | 2026-05-01 | 4,158 |
| McGee Grant B | General Counsel & Secretary | Option exercise | 2026-05-01 | 1,160 |
| Melucci Jeffrey P. | Chief Bus., Strat. & Admin. | Option exercise | 2026-05-01 | 3,046 |
| Hsu Michael D. | Chairman of the Board and CEO | Option exercise | 2026-05-01 | 11,122 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-31 | Corsi Patricia | Chief Growth Officer | Option exercise | 966 | $0.00 |
| 2026-07-31 | Corsi Patricia | Chief Growth Officer | Tax withholding | 404 | $109.31 |
| 2026-07-31 | Slavtcheff Craig | Chief R&D Officer | Option exercise | 4,024 | $0.00 |
| 2026-07-31 | Slavtcheff Craig | Chief R&D Officer | Option exercise | 1,255 | $0.00 |
| 2026-07-31 | Slavtcheff Craig | Chief R&D Officer | Tax withholding | 534 | $109.31 |
| 2026-07-31 | Slavtcheff Craig | Chief R&D Officer | Tax withholding | 1,711 | $109.31 |
| 2026-05-06 | Scribner Andrew | Controller, VP & FP&A | Open market sale | 4,095 | $98.00 |
| 2026-05-04 | Chen Katy | President, Int'l Personal Care | Open market sale | 1,596 | $95.34 |
| 2026-05-01 | Chen Katy | President, Int'l Personal Care | Option exercise | 1,740 | $0.00 |
| 2026-05-01 | Chen Katy | President, Int'l Personal Care | Option exercise | 1,716 | $0.00 |
| 2026-05-01 | Corsi Patricia | Chief Growth Officer | Option exercise | 966 | $0.00 |
| 2026-05-01 | Corsi Patricia | Chief Growth Officer | Tax withholding | 403 | $97.67 |
| 2026-05-01 | Abou-Oaf Ehab | Pres. Int'l Fam. Care & Prof. | Option exercise | 1,450 | $0.00 |
| 2026-05-01 | Abou-Oaf Ehab | Pres. Int'l Fam. Care & Prof. | Option exercise | 1,430 | $0.00 |
| 2026-05-01 | Slavtcheff Craig | Chief R&D Officer | Option exercise | 1,257 | $0.00 |
| 2026-05-01 | Slavtcheff Craig | Chief R&D Officer | Tax withholding | 535 | $97.67 |
| 2026-05-01 | Scribner Andrew | Controller, VP & FP&A | Option exercise | 665 | $0.00 |
| 2026-05-01 | Scribner Andrew | Controller, VP & FP&A | Option exercise | 655 | $0.00 |
| 2026-05-01 | Scribner Andrew | Controller, VP & FP&A | Tax withholding | 160 | $97.67 |
| 2026-05-01 | Scribner Andrew | Controller, VP & FP&A | Tax withholding | 162 | $97.67 |
| 2026-05-01 | Fenske Tamera | Chief Supply Chain Officer | Option exercise | 2,582 | $0.00 |
| 2026-05-01 | Fenske Tamera | Chief Supply Chain Officer | Option exercise | 1,450 | $0.00 |
| 2026-05-01 | Fenske Tamera | Chief Supply Chain Officer | Option exercise | 1,430 | $0.00 |
| 2026-05-01 | Fenske Tamera | Chief Supply Chain Officer | Tax withholding | 637 | $97.67 |
| 2026-05-01 | Fenske Tamera | Chief Supply Chain Officer | Tax withholding | 647 | $97.67 |
| 2026-05-01 | Fenske Tamera | Chief Supply Chain Officer | Tax withholding | 1,151 | $97.67 |
| 2026-05-01 | Urdaneta Nelson | Chief Financial Officer | Option exercise | 3,384 | $0.00 |
| 2026-05-01 | Urdaneta Nelson | Chief Financial Officer | Option exercise | 3,337 | $0.00 |
| 2026-05-01 | Urdaneta Nelson | Chief Financial Officer | Tax withholding | 1,314 | $97.67 |
| 2026-05-01 | Urdaneta Nelson | Chief Financial Officer | Tax withholding | 1,332 | $97.67 |
| 2026-05-01 | Torres Russell | President and COO | Option exercise | 4,158 | $0.00 |
| 2026-05-01 | Torres Russell | President and COO | Option exercise | 3,146 | $0.00 |
| 2026-05-01 | Torres Russell | President and COO | Tax withholding | 1,239 | $97.67 |
| 2026-05-01 | Torres Russell | President and COO | Tax withholding | 1,637 | $97.67 |
| 2026-05-01 | McGee Grant B | General Counsel & Secretary | Option exercise | 1,160 | $0.00 |
| 2026-05-01 | McGee Grant B | General Counsel & Secretary | Option exercise | 1,144 | $0.00 |
| 2026-05-01 | McGee Grant B | General Counsel & Secretary | Tax withholding | 451 | $97.67 |
| 2026-05-01 | McGee Grant B | General Counsel & Secretary | Tax withholding | 457 | $97.67 |
| 2026-05-01 | Melucci Jeffrey P. | Chief Bus., Strat. & Admin. | Option exercise | 3,046 | $0.00 |
| 2026-05-01 | Melucci Jeffrey P. | Chief Bus., Strat. & Admin. | Option exercise | 3,004 | $0.00 |
| 2026-05-01 | Melucci Jeffrey P. | Chief Bus., Strat. & Admin. | Tax withholding | 1,183 | $97.67 |
| 2026-05-01 | Melucci Jeffrey P. | Chief Bus., Strat. & Admin. | Tax withholding | 1,199 | $97.67 |
| 2026-05-01 | Hsu Michael D. | Chairman of the Board and CEO | Option exercise | 11,122 | $0.00 |
| 2026-05-01 | Hsu Michael D. | Chairman of the Board and CEO | Option exercise | 10,490 | $0.00 |
| 2026-05-01 | Hsu Michael D. | Chairman of the Board and CEO | Tax withholding | 4,128 | $97.67 |
| 2026-05-01 | Hsu Michael D. | Chairman of the Board and CEO | Tax withholding | 4,377 | $97.67 |
| 2026-04-30 | Chen Katy | President, Int'l Personal Care | Open market sale | 1,405 | $96.95 |
| 2026-04-26 | Scribner Andrew | Controller, VP & FP&A | Grant / award | 3,234 | $0.00 |
| 2026-04-26 | Scribner Andrew | Controller, VP & FP&A | Option exercise | 862 | $0.00 |
| 2026-04-26 | Scribner Andrew | Controller, VP & FP&A | Tax withholding | 211 | $97.85 |
| 2026-04-26 | Scribner Andrew | Controller, VP & FP&A | Tax withholding | 788 | $97.85 |
| 2026-04-26 | Fenske Tamera | Chief Supply Chain Officer | Grant / award | 10,585 | $0.00 |
| 2026-04-26 | Fenske Tamera | Chief Supply Chain Officer | Option exercise | 1,882 | $0.00 |
| 2026-04-26 | Fenske Tamera | Chief Supply Chain Officer | Tax withholding | 839 | $97.85 |
| 2026-04-26 | Fenske Tamera | Chief Supply Chain Officer | Tax withholding | 4,715 | $97.85 |
| 2026-04-26 | Chen Katy | President, Int'l Personal Care | Grant / award | 3,087 | $0.00 |
| 2026-04-26 | Chen Katy | President, Int'l Personal Care | Option exercise | 823 | $0.00 |
| 2026-04-26 | Abou-Oaf Ehab | Pres. Int'l Fam. Care & Prof. | Grant / award | 9,173 | $0.00 |
| 2026-04-26 | Abou-Oaf Ehab | Pres. Int'l Fam. Care & Prof. | Option exercise | 1,631 | $0.00 |
| 2026-04-26 | Urdaneta Nelson | Chief Financial Officer | Grant / award | 19,053 | $0.00 |
Showing the most recent 60 transactions.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 06:45 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-20 | 8-K | 2026-10-19 | View on SEC.gov → |
| 2026-10-15 | 8-K | 2026-10-15 | View on SEC.gov → |
| 2026-10-13 | 8-K | 2026-10-09 | View on SEC.gov → |
| 2026-10-01 | 8-K | 2026-09-29 | View on SEC.gov → |
| 2026-09-28 | 8-K | 2026-09-28 | View on SEC.gov → |
| 2026-08-04 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-04 | 4 | 2026-07-31 | View on SEC.gov → |
| 2026-08-04 | 4 | 2026-07-31 | View on SEC.gov → |
| 2026-08-04 | 8-K | 2026-08-04 | View on SEC.gov → |
| 2026-05-14 | 8-K | 2026-05-14 | View on SEC.gov → |
| 2026-05-06 | 4 | 2026-05-06 | View on SEC.gov → |
| 2026-05-05 | 8-K | 2026-05-01 | View on SEC.gov → |
Recent news
Headlines about KMB (Kimberly-Clark Corporation). Links open the publisher — we don’t host full articles.
-
Kimberly-Clark de México Delivers Margin Gains and Strong Cash Position in Third Quarter 2026
The Globe and Mail · 2026-10-22 -
Kimberly-Clark Corporation (KMB) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-22 -
Jim Cramer Calls Kimberly-Clark a Hated Dividend King. Is He Right?
Yahoo · 2026-10-21 -
Kenvue to Announce Third Quarter 2026 Results on October 30, 2026
Yahoo · 2026-10-21 -
Kimberly-Clark vs. Clorox: The Higher Yield May Not Be the Better Dividend
Yahoo · 2026-10-21 -
Kimberly-Clark Mexico stock: Barclays keeps Hold at MXN 43.00
AD HOC NEWS · 2026-10-21 -
Kimberly-Clark Mexico reports 25.5 percent margin while Kimberly-Clark Mexico stock costs EUR 1.87
AD HOC NEWS · 2026-10-21 -
Better Dividend Stock for Retirees: Target vs. Kimberly-Clark
Yahoo · 2026-10-20
No headlines in this category right now — try “All”.